Primary Objective
To compare the prevalence of ototoxicity and neurotoxicity in GCT cancer survivors who only had surgery to a similar population from The Platinum Study (RSRB45410/1305011509) who received cisplatin-based combination chemotherapy.
Secondary Objective
To compare the prevalence of obesity, hypertension, and use of antidepressants/anxiolytics in GCT cancer survivors who only had surgery to a similar population from The Platinum Study who received cisplatin-based combination chemotherapy.
Inclusion Criteria:
- Diagnosis or confirmation of diagnosis of a histologically or serologically confirmed
testicular germ cell tumor (GCT) or GCT at another anatomic location
- Age at GCT diagnosis: 55 years of age or younger
- Males, 18 years of age or older at time of study consent
- Subject is able to provide consent
- Subject is able to speak and read English
- Treatment consisted of surgery only (i.e., orchiectomy and/or retroperitoneal lymph
node dissection [RPLND]) for either initial testicular germ cell tumor (GCT) or
subsequent testicular cancer
- Subject completed surgery > 1 year ago
- Subject is currently undergoing active follow-up at IU
- Subject did not require any subsequent chemotherapy, salvage chemotherapy treatment or
bone marrow transplant.
- Subject had no prior chemotherapy of any kind
Exclusion Criteria:
- Patients with prior chemotherapy (whether for GCT or any other cancer)
Any Site
Other Male Genital